NCT06727448 Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health
| NCT ID | NCT06727448 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Chronic Insomnia Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-12-23 |
| Primary Completion | 2026-06-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-12-23 with a primary completion date of 2026-06-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sleep is an essential function for physical and mental health. The mismatch between biological rhythms and the social rhythms of individuals is increasingly common in modern societies. This sleep irregularity can have numerous consequences on mental health, cardiometabolic health, the immune system, functioning, and quality of life. To address the public health issue of sleep irregularity, it is important to be able to obtain a valid and reliable measure. The Sleep Regularity Questionnaire (SRQ) by Dzierzewski et al. addresses this issue, but has never been translated into French. The aim of the study is to translate and validate the French version of the Sleep Regularity Questionnaire.
Eligibility Criteria
Inclusion Criteria: * Patient ≥ 18 years of age * Patient with indication for 14-day actimetry for chronic insomnia or circadian rhythm disorder * Patients with an indication for 14-day actimetry to assess sleep-wake rhythms, for example prior to a 36-hour polysomnographic recording to diagnose central hypersomnia (narcolepsy or idiopathic hypersomnia). * Patient affiliated to or benefiting from a social security scheme * Patient with French as mother tongue, able to read and write French. * Patient able to understand and complete questionnaires independently * Patient informed and not opposed to participating in the study Exclusion Criteria: * Current psychiatric disorder (mood disorders, anxiety, psychosis, sleep-interfering use disorder) assessed during interview with investigator * Current neurological disorder affecting sleep (neurodegenerative disease, stroke, epilepsy) assessed during interview with investigator * Unstable cardiovascular or respiratory diseases * Pregnant or breast-feeding women * Adults under guardianship or curatorship * Opposition to participation expressed by healthy patient/volunteer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06727448 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Insomnia Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06727448 currently recruiting?
Yes, NCT06727448 is actively recruiting participants. Contact the research team at Julien.coelho@chu-bordeaux.fr for enrollment information.
Where is the NCT06727448 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT06727448 clinical trial?
NCT06727448 is sponsored by University Hospital, Bordeaux. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.